Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland.

To access publisher's full text version of this article. Please click on the hyperlink in Additional Links field. Multiple system atrophy (MSA) is a neurodegenerative disorder characterised by autonomic dysfunction with parkinsonism (MSAp) or cerebellar (MSAc) symptoms. At autopsy, α-synuclein...

Full description

Bibliographic Details
Published in:Journal of Neurology, Neurosurgery & Psychiatry
Main Authors: Bjornsdottir, Anna, Gudmundsson, Gretar, Blondal, Hannes, Olafsson, Elias
Other Authors: Univ Hosp, Dept Neurol, Landspitali, IS-108 Reykjavik, Iceland, United Hosp, Dept Pathol, Landspitali, Reykjavik, Iceland, Univ Iceland, Fac Med, Reykjavik, Iceland
Format: Article in Journal/Newspaper
Language:English
Published: Amer Soc Hematology 2013
Subjects:
Taugasjúkdómar
Lífslíkur
Age of Onset
Aged
80 and over
Brain
Female
Humans
Iceland
Incidence
Male
Middle Aged
Multiple System Atrophy
Prevalence
Survival Rate
alpha-Synuclein
Online Access:http://hdl.handle.net/2336/312623
https://doi.org/10.1136/jnnp-2012-302500
Description
Summary:To access publisher's full text version of this article. Please click on the hyperlink in Additional Links field. Multiple system atrophy (MSA) is a neurodegenerative disorder characterised by autonomic dysfunction with parkinsonism (MSAp) or cerebellar (MSAc) symptoms. At autopsy, α-synuclein inclusions in glial cells of the brain are needed to confirm a definite diagnosis. We determined the 10 year incidence of MSA, point prevalence and survival in a well defined population with a high number of neurologists. Landspitali University Hospital Research Fund

Similar Items